Efficacy of Adapted Physical Activity on a Walking Platform in Elderly Patients HOspitalized for Cancer Surgery

NCT ID: NCT06201884

Last Updated: 2024-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE2

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-15

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to evaluate the efficacy of daily use of a walking platform to improve recovery of preoperative walking speed at hospital discharge following oncological surgery in patients aged 65 or older.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oncology Elderly Patients Surgery

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Adapted physical activity walking platform

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adapted physical activity

Adapted physical activity on a walking platform

Group Type EXPERIMENTAL

Early rehabilitation through Adapted Physical Activity

Intervention Type DEVICE

From the day after surgery, 1 to 2 walking sessions with walking platform, lasting 6 to 30 minutes (min-max), will be proposed daily until the day of discharge.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early rehabilitation through Adapted Physical Activity

From the day after surgery, 1 to 2 walking sessions with walking platform, lasting 6 to 30 minutes (min-max), will be proposed daily until the day of discharge.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men or women aged 65 or over
* Candidate for scheduled major oncological surgery and/or surgery with high morbidity
* Patient able to walk for 10 minutes on the walking platform at the time of the test
* Patient affiliated to a social security system
* Signature of informed consent prior to any specific study-related procedure

Exclusion Criteria

* Patient with severe undernutrition (BMI\<18, and/or weight loss \>15% in 6 months or \>10% in 1 month)
* Emergency surgery
* Physical contraindications preventing use of the platform
* Simultaneous participation in another clinical study that could compromise the conduct of this study
* Patients deprived of their liberty, under guardianship or subject to a legal protection measure, or unable to express their consent.
* Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Francois Baclesse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Francois Baclesse

Caen, , France

Site Status RECRUITING

CHU CAEN

Caen, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Heidi LAVIEC, MD

Role: CONTACT

Phone: 0231455050

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Heidi LAVIEC, MD

Role: primary

Bérengère BEAUPLET, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A01292-43

Identifier Type: -

Identifier Source: org_study_id